We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
601
Charles Schwab
SCHW
$189B
$275K 0.05%
+3,795
New +$250K
XPO icon
602
XPO
XPO
$23.6B
$274K 0.05%
2,246
-257
-10% -$27.5K
XMTR icon
603
Xometry
XMTR
$5.22B
$274K 0.05%
+16,219
New +$440K
CCC
604
CCC Intelligent Solutions
CCC
$4.09B
$274K 0.05%
22,904
-29,975
-57% -$342K
MOH icon
605
Molina Healthcare
MOH
$10.4B
$274K 0.05%
666
-2,594
-80% -$1.01M
EDIT icon
606
Editas Medicine
EDIT
$439M
$273K 0.05%
36,858
+24,005
+187% +$199K
SIGA icon
607
SIGA Technologies
SIGA
$207M
$273K 0.05%
+31,877
New +$182K
BURL icon
608
Burlington
BURL
$23.4B
$271K 0.05%
+1,169
New +$239K
CVX icon
609
Chevron
CVX
$381B
$271K 0.05%
+1,716
New +$259K
ITCI
610
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$271K 0.05%
+3,911
New +$269K
AZTA icon
611
Azenta
AZTA
$1.53B
$268K 0.05%
+4,441
New +$284K
LTH icon
612
Life Time Group Holdings
LTH
$9.55B
$267K 0.05%
+17,188
New +$239K
CCB icon
613
Coastal Financial
CCB
$732M
$266K 0.05%
+6,856
New +$271K
BLFS icon
614
BioLife Solutions
BLFS
$1.69B
$266K 0.05%
+14,348
New +$251K
NVRI icon
615
Enviri
NVRI
$620M
$266K 0.05%
+29,085
New +$244K
TEAD
616
Teads Holding Co
TEAD
$62.4M
$265K 0.05%
67,147
+45,168
+206% +$181K
SHBI icon
617
Shore Bancshares
SHBI
$786M
$264K 0.05%
+22,955
New +$275K
NFBK
618
DELISTED
Northfield Bancorp
NFBK
$264K 0.05%
+27,152
New +$298K
CMRC
619
Commerce.com Inc Series 1
CMRC
$176M
$264K 0.05%
+38,286
New +$307K
UTHR icon
620
United Therapeutics
UTHR
$22.5B
$264K 0.05%
1,148
-5,311
-82% -$1.2M
VGR
621
DELISTED
Vector Group Ltd.
VGR
$262K 0.05%
+23,906
New +$260K
IRWD icon
622
Ironwood Pharmaceuticals
IRWD
$674M
$262K 0.05%
+30,074
New +$365K
BY icon
623
Byline Bancorp
BY
$1.74B
$262K 0.05%
+12,054
New +$260K
LGF.A
624
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$260K 0.05%
+26,094
New +$258K
ESE icon
625
ESCO Technologies
ESE
$7.82B
$259K 0.05%
+2,415
New +$248K
23 24
25
26 27

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.